Inovise's Audicor 200 enters Hong Kong:
This article was originally published in Clinica
Executive Summary
Inovise Medical's Audicor 200 system, designed to diagnose heart failure and other cardiac conditions noninvasively, is to make its debut in Hong Kong. The device's Portland, Oregon-based developer has appointed Goodwin Health Care, claimed to be Hong Kong's leading supplier of medical products and services to hospitals and the emergency care sector, as distributor of the Audicor 200 in the country. The agreement expands Inovise's presence in Asia, where it has a subsidiary in Taiwan and a development and commercialisation partnership with Nihon Kohden of Japan.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.